Article Text

Download PDFPDF
Combination of Scoring Criteria and Whole Exome Sequencing Analysis of Synchronous Endometrial and Ovarian Carcinomas
  1. Lingyi Yang, MD*,
  2. Lin Zhang, BD,
  3. Qiujuan Huang, MD*,
  4. Changxu Liu, MD*,
  5. Lisha Qi, PhD*,
  6. Lingmei Li, MD*,
  7. Tongyuan Qu, MD*,
  8. Yalei Wang, MD*,
  9. Suxiang Liu, BD*,
  10. Bin Meng, PhD*,
  11. Baocun Sun, MD* and
  12. Wenfeng Cao, PhD*
  1. * Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Center Prevention and Therapy, Tianjin's Clinical Research Center for Cancer; and
  2. Department of Pathology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin, China.
  1. Address correspondence and reprint requests to Wenfeng Cao, PhD, Tianjin Medical University Cancer Institute and Hospital, Huanhu West Road, Hexi District, Tianjin 300060, China. E-mail: caowenfeng{at}tjmuch.com.

Abstract

Objectives The purpose of this study was to distinguish synchronous primary endometrial and ovarian carcinomas from single primary tumor with metastasis by clinical pathologic criteria and whole exome sequencing (WES).

Material and Methods Fifty-two patients with synchronous endometrial and ovarian carcinomas (SEOCs) between 2010 and 2017 were reviewed and subjected to WES.

Results On the basis of the Scully criteria, 11 cases were supposed as synchronous primary endometrial and ovarian carcinomas, 38 cases as single primary tumor with metastasis, and the remaining 3 cases (S50–S52) cannot be defined. Through a quantization scoring analysis, 9 cases that were scored 0–1 point were defined as synchronous primary endometrial and ovarian carcinomas, and 42 cases that were scored 3–8 points were defined as single primary tumor with metastasis. Two of the undefined cases were classified into metastatic disease, and another one that scored 2 points (S52) was subjected to WES. S52 was deemed synchronous primary endometrial and ovarian carcinomas, with few shared somatic mutations and overlapping copy number varieties. The finding of a serous component examined from the uterine endometrium samples further illustrated that the case was synchronous primary endometrial and ovarian carcinomas.

Conclusion By scoring criterion, SEOCs were divided into 2 groups: synchronous primary endometrial and ovarian carcinoma group and single primary tumor with metastasis group. The analysis of clonality indicated that the case that scored 2 (S52) can be considered as synchronous primary endometrial and ovarian carcinomas. Scoring criteria of clinical pathology, along with the study of the WES, may further identify the classification of SEOCs.

  • Synchronous
  • Endometrial carcinoma
  • Ovarian carcinoma
  • Scoring criteria
  • Whole exome sequencing

Statistics from Altmetric.com

Footnotes

  • The authors declare no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.